DXCM vs. RMD
Compare and contrast key facts about DexCom, Inc. (DXCM) and ResMed Inc. (RMD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DXCM or RMD.
Correlation
The correlation between DXCM and RMD is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
DXCM vs. RMD - Performance Comparison
Loading data...
Key characteristics
DXCM:
-0.58
RMD:
0.51
DXCM:
-0.40
RMD:
0.84
DXCM:
0.92
RMD:
1.12
DXCM:
-0.52
RMD:
0.43
DXCM:
-0.84
RMD:
1.93
DXCM:
39.31%
RMD:
8.23%
DXCM:
58.70%
RMD:
33.76%
DXCM:
-94.61%
RMD:
-61.60%
DXCM:
-46.59%
RMD:
-11.96%
Fundamentals
DXCM:
$33.52B
RMD:
$36.90B
DXCM:
$1.33
RMD:
$8.91
DXCM:
64.27
RMD:
28.25
DXCM:
1.32
RMD:
1.50
DXCM:
8.08
RMD:
7.35
DXCM:
14.79
RMD:
6.65
DXCM:
$4.15B
RMD:
$5.02B
DXCM:
$2.46B
RMD:
$2.94B
DXCM:
$889.80M
RMD:
$1.71B
Returns By Period
The year-to-date returns for both stocks are quite close, with DXCM having a 11.82% return and RMD slightly lower at 11.27%. Both investments have delivered pretty close results over the past 10 years, with DXCM having a 17.61% annualized return and RMD not far behind at 17.52%.
DXCM
11.82%
26.82%
14.02%
-33.80%
2.69%
-2.75%
17.61%
RMD
11.27%
19.25%
6.29%
16.96%
9.62%
10.31%
17.52%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DXCM vs. RMD — Risk-Adjusted Performance Rank
DXCM
RMD
DXCM vs. RMD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for DexCom, Inc. (DXCM) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
DXCM vs. RMD - Dividend Comparison
DXCM has not paid dividends to shareholders, while RMD's dividend yield for the trailing twelve months is around 0.84%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DXCM DexCom, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RMD ResMed Inc. | 0.84% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% | 1.89% |
Drawdowns
DXCM vs. RMD - Drawdown Comparison
The maximum DXCM drawdown since its inception was -94.61%, which is greater than RMD's maximum drawdown of -61.60%. Use the drawdown chart below to compare losses from any high point for DXCM and RMD. For additional features, visit the drawdowns tool.
Loading data...
Volatility
DXCM vs. RMD - Volatility Comparison
DexCom, Inc. (DXCM) has a higher volatility of 17.10% compared to ResMed Inc. (RMD) at 9.85%. This indicates that DXCM's price experiences larger fluctuations and is considered to be riskier than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
DXCM vs. RMD - Financials Comparison
This section allows you to compare key financial metrics between DexCom, Inc. and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DXCM vs. RMD - Profitability Comparison
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a gross profit of 589.00M and revenue of 1.04B. Therefore, the gross margin over that period was 56.9%.
RMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, ResMed Inc. reported a gross profit of 766.41M and revenue of 1.29B. Therefore, the gross margin over that period was 59.3%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported an operating income of 133.70M and revenue of 1.04B, resulting in an operating margin of 12.9%.
RMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, ResMed Inc. reported an operating income of 426.27M and revenue of 1.29B, resulting in an operating margin of 33.0%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a net income of 105.40M and revenue of 1.04B, resulting in a net margin of 10.2%.
RMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, ResMed Inc. reported a net income of 365.04M and revenue of 1.29B, resulting in a net margin of 28.3%.